Modulation of MHC class I/II antigens and cell surface glycoconjugates by the fusion IL6/IL2 transduction.

被引:0
|
作者
Yu, HD [1 ]
Tang, PH [1 ]
Zhao, CH [1 ]
Huang, Y [1 ]
Liu, YL [1 ]
Mao, N [1 ]
机构
[1] SINOCHEM INST BIOTECHNOL,INST BASIC MED SCI,BEIJING,PEOPLES R CHINA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:386 / 386
页数:1
相关论文
共 50 条
  • [31] FLUORESCENT LABELING OF A COMMON CELL-SURFACE PROTEIN WITH AN INTRINSIC PROBE - EXCHANGE OF FITC BETA-2-MICROGLOBULIN INTO CLASS-I MHC ANTIGENS ON LIVING CELLS
    HOCHMAN, J
    WEI, T
    WEIR, M
    EDIDIN, M
    BIOPHYSICAL JOURNAL, 1986, 49 (02) : A357 - A357
  • [32] CYTOMEGALOVIRUS INFECTION MK2-DEPENDENTLY LEADS TO A DECREASED IFN-γ/IL-10 RATIO WHICH LIMITS MHC CLASS I/II EXPRESSION AND PREVENTS FORMATION OF MONONUCLEAR CELL INFILTRATES WITHIN THE LIVER
    Ehlting, C.
    Trilling, M.
    Tiedje, C.
    Zimmermann, A.
    Le, V. T. K.
    Gaestel, M.
    Hengel, H.
    Haeussinger, D.
    Bode, J. G.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S110 - S110
  • [33] INDUCED-DIFFERENTIATION OF A B-CELL CLONE - ROLE OF SURFACE-IMMUNOGLOBULIN (IG), CLASS-II ANTIGEN, AND IL-2 RECEPTOR
    BISHOP, GA
    HAUGHTON, G
    FEDERATION PROCEEDINGS, 1986, 45 (03) : 714 - 714
  • [34] ANTIGEN-SPECIFIC RECOGNITION OF AUTOLOGOUS LEUKEMIA-CELLS AND ALLOGENEIC CLASS-I MHC ANTIGENS BY IL-2-ACTIVATED CYTO-TOXIC T-CELLS FROM A PATIENT WITH ACUTE T-CELL LEUKEMIA
    FISCH, P
    WEILHILLMAN, G
    UPPENKAMP, M
    HANK, JA
    CHEN, BP
    SOSMAN, JA
    BRIDGES, A
    COLAMONICI, OR
    SONDEL, PM
    BLOOD, 1989, 74 (01) : 343 - 353
  • [35] IL-2R, CD4 AND MHC CLASS-II ANTIGEN EXPRESSION BY HUMAN T-CELL LEUKEMIA VIRUS-I (HTLV-1) INFECTED HUMAN MONOCYTES AND MACROPHAGES (HMO)
    VENKATESHEN, CN
    STONE, GA
    JOHNSON, BK
    LE, HN
    CHENG, S
    GAJDUSEK, DC
    GIBBS, CJ
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1994, 10 : S125 - S125
  • [36] LATERAL ORGANIZATION OF THE ICAM-1 MOLECULE AT THE SURFACE OF HUMAN LYMPHOBLASTS - A POSSIBLE MODEL FOR ITS CODISTRIBUTION WITH THE IL-2 RECEPTOR, CLASS-I AND CLASS-II HLA MOLECULES
    BENE, L
    BALAZS, M
    MATKO, J
    MOST, J
    DIERICH, MP
    SZOLLOSI, J
    DAMJANOVICH, S
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1994, 24 (09) : 2115 - 2123
  • [37] Phase I/II clinical trial of ALT-801, a T-cell receptor/IL-2 fusion protein, plus gemcitabine and cisplatin in urothelial cancer
    Fishman, Mayer N.
    Hadjenberg, Julio
    Kuzel, Timothy
    Mahipal, Amit
    Rosser, Charles Joel
    Landau, Danny
    Gupta, Shilpa
    Vaena, Daniel A.
    Agarwala, Sanjiv S.
    Mahoney, John Francis
    Hoffman-Censits, Jean H.
    Harris, Wayne
    Milhem, Mohammed M.
    Weber, Jeffrey S.
    Rhode, Peter
    Schutt, Tessa
    Hernandez, Liza
    Huang, Bee-Yau
    Wong, Hing C.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)
  • [38] NOD-scid IL2rgnull (NSG) mice deficient in murine MHC Class I and Class II expression support engraftment of functional human T cells in the absence of acute xenogeneic GVHD following injection of PBMC
    Brehm, Michael A.
    Wiles, Michael
    Kenney, Laurie Lea
    Burzenski, Lisa
    Keck, James
    Greiner, Dale L.
    Shultz, Leonard D.
    JOURNAL OF IMMUNOLOGY, 2018, 200 (01):
  • [39] NOD-scid IL2rgnull (NSG) mice deficient in murine MHC Class I and Class II expression support engraftment of functional human T cells in the absence of acute xenogeneic GVHD following injection of PBMC
    Brehm, Michael A.
    Wiles, Michael
    Kenney, Laurie
    Low, Ben
    Tisch, Roland M.
    Burzenski, Lisa
    Keck, James G.
    Greiner, Dale L.
    Shultz, Leonard D.
    CANCER RESEARCH, 2018, 78 (13)
  • [40] DEMONSTRATION OF MHC CLASS I-SPECIFIC CYTOLYTIC ACTIVITY IN IL-2-ACTIVATED NK1(+)CD3(+) CELLS AND EVIDENCE OF USAGE OF T-CELL AND NK-CELL RECEPTORS
    TAKEDA, K
    DENNERT, G
    TRANSPLANTATION, 1994, 58 (04) : 496 - 504